PLOS 03/10/16 Climate Change Influences on the Global Potential Distribution of the Mosquito Culex quinquefasciatus, Vector of West Nile Virus and Lymphatic Filariasis. Abstract Rapid emergence of most vector-borne diseases (VBDs) may be associated with range expansion of vector populations.
Culex quinquefasciatus Say 1823 is a potential vector of West Nile virus, Saint Louis encephalitis virus, and lymphatic filariasis. We estimated the potential distribution of Cx. quinquefasciatus under both current and future climate conditions. The present potential distribution of Cx. quinquefasciatus showed high suitability across low-latitude parts of the world, reflecting the current distribution of the species.
Suitable conditions were identified also in narrow zones of North Africa and Western Europe. Citation: Samy AM, Elaagip AH, Kenawy MA, Ayres CFJ, Peterson AT, Soliman DE (2016) Climate Change Influences on the Global Potential Distribution of the Mosquito Culex quinquefasciatus, Vector of West Nile Virus and Lymphatic Filariasis. Editor: Shannon L. Received: April 5, 2016; Accepted: September 15, 2016; Published: October 3, 2016 Introduction Results. PLOS 19/05/17 Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis. Abstract Background During the past 20 years, enormous efforts have been expended globally to eliminate lymphatic filariasis (LF) through mass drug administration (MDA).
However, small endemic foci (microfoci) of LF may threaten the presumed inevitable decline of infections after MDA cessation. We conducted microsimulation modeling to assess the ability of different types of surveillance to identify microfoci in these settings. Methods Five or ten microfoci of radius 1, 2, or 3 km with infection marker prevalence (intensity) of 3, 6, or 10 times background prevalence were placed in spatial simulations, run in R Version 3.2.
Results All variables were significantly associated with efficiency metrics. Conclusion. IRD 24/04/17 Filariose lymphatique : une nouvelle stratégie de lutte. © DOLF Project L'équipe de recherche réalise le dépistage de la filariose lymphatique Chez les patients atteints de la maladie de la loase, le traitement préventif de la filariose lymphatique peut provoquer un accident thérapeutique.
Une nouvelle stratégie médicamenteuse communautaire prenant en compte ce contexte particulier vient de montrer son efficacité en République du Congo. Ils sont 947 millions d’individus devant recevoir un traitement médicamenteux afin de prévenir la propagation de la filariose lymphatique. Cette maladie tropicale négligée communément appelée éléphantiasis provoque un gonflement des membres. Stigmatisante et handicapante pour les populations qui en souffrent, elle est due à une infection par des vers filaires adultes. Afin d’enrayer la propagation de cette pathologie d’ici 2020, l’OMS préconise l’administration annuelle de deux médicaments associés, l’albendazole et l’ivermectine.
HANDICAP INTERNATIONAL via YOUTUBE - 2015 - Prévention des incapacités dues à la filariose lymphatique à Madagascar. Cec Ugc via YOUTUBE 03/08/15 Vector Borne Diseases : Leishmaniasis & Lymphatic Filariasis. Parasitol Res. 2017 Mar;116(3):963-970. Molecular identification and phylogenetic analysis of Wuchereria bancrofti from human blood samples in Egypt. PLOS 16/02/17 Partnering for impact: Integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti. Abstract Background Since 2001, Haiti’s National Program for the Elimination of Lymphatic Filariasis (NPELF) has worked to reduce the transmission of LF through annual mass drug administration with diethylcarbamazine and albendazole.
The NPELF reached full national coverage with MDA for LF in 2012, and by 2014, a total of 14 evaluation units (48 communes) had met WHO eligibility criteria to conduct LF transmission assessment surveys (TAS) to determine whether prevalence had been reduced to below a threshold, such that transmission is assumed to be no longer sustainable. ASSAM JOURNAL OF INTERNATL MEDICINE - JANV 2017 - USG Scrotum as an Important Investigating Tool for Lymphatic Filariasis. Indian Journal of Public Health Research & Development, April-June 2016, Vol. 7, No. 2 Prevalence of Lymphatic Filariasis and Economic Impact of Chronic Forms of the Disease in a Group of Weavers in the Godavari Districts of Andhra Pradesh.
SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH - MAI 2012 - Geographic information system (GIS) mapping of lymphatic filariasis endemic areas of Gampaha district, Sri Lanka based on epidemiological and entomological screening. SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH - NOV 2014 - PREVALENCE OF LYMPHATIC FILARIASIS, MALARIA AND SOIL TRANSMITTED HELMINTHIASIS IN A COMMUNITY OF BARDIYA DISTRICT, WESTERN NEPAL. Acta Tropica Volume 135, July 2014, Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: A systematic review. Highlights We conducted a systematic review on the costs of LF and onchocerciasis.
A total of 24 papers were identified for onchocerciasis and 52 papers for LF. Research gaps exist on the cost of integrating NTD prevention and control programs. The cost literature is generally older and extremely focal geographically. Transactions of the Royal Society of Tropical Medicine and Hygiene Volume 106, Issue 2, February 2012, Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic a. THE LANCET - MARS 2016 - Reducing the population requiring interventions against lymphatic filariasis in Africa. Asian Pacific Journal of Tropical Disease Volume 6, Issue 7, July 2016, Lymphatic filariasis: Surveillance action among immigrants from endemic areas, Acre State, Brazilian Amazon.
Abstract Objective To investigate the positivity of Wuchereria bancrofti (W. bancrofti) in immigrants who entered the country through Rio Branco, reducing the risk of introduction of parasites into new areas and endemic areas of the past.
Methods It was realized a descriptive study. The AD12-ICT card test was applied on all immigrants living temporarily in the Chacara Alliance shelter, located in the metropolitan area of Rio Branco-AC, Brazil. Results The present study evaluated 415 individuals in September 2014 by circulating filarial antigen for W. bancrofti using the AD12-ICT card test. Conclusions This surveillance action reveals, in a pioneering and unequivocal manner, that Brazil is an influx of immigrants carrying lymphatic filariasis and there is an urgent need to step up surveillance at the main entry point for immigrants. Trends in Parasitology Volume 33, Issue 2, February 2017, Can Lymphatic Filariasis Be Eliminated by 2020? Interventions against neglected tropical diseases (NTD), including lymphatic filariasis (LF), scaled up dramatically after the signing of the London Declaration (LD) in 2012.
LF is targeted for elimination by 2020, but some countries are considered not on track to meet the 2020 target using the recommended preventive chemotherapy and morbidity management strategies. In this Opinion article we review the prospects for achieving LF elimination by 2020 in the light of the renewed global action against NTDs and the global efforts to achieve the sustainable development goals (SDGs) by 2030. We conclude that LF can be eliminated by 2020 using cross-sectoral and integrated approaches because of the compound effect of the other SDG activities related to poverty reduction and water and sanitation. Osong Public Health and Research Perspectives Volume 3, Issue 3, September 2012 Surveillance and Vector Control of Lymphatic Filariasis in the Republic of Korea.
Abstract Objectives Until the early 2000s, lymphatic filariasis would commonly break out in the coastal areas in Korea.
PLoS Negl Trop Dis 8(12): e3328. doi:10.1371/journal.pntd.0003328 Editor: John Owusu Gyapong, University of Ghana, Ghana Published: December 11, 2014 This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. PLOS 27/12/11 The Emerging Story of Disability Associated with Lymphatic Filariasis: A Critical Review. Abstract Globally, 40 million people live with the chronic effects of lymphatic filariasis (LF), making it the second leading cause of disability in the world. Despite this, there is limited research into the experiences of people living with the disease. This review summarises the research on the experiences of people living with LF disability.
The review highlights the widespread social stigma and oppressive psychological issues that face most people living with LF-related disability. PLOS 05/11/15 Shrinking the Lymphatic Filariasis Map of Ethiopia: Reassessing the Population at Risk through Nationwide Mapping. Abstract Background Mapping of lymphatic filariasis (LF) is essential for the delineation of endemic implementation units and determining the population at risk that will be targeted for mass drug administration (MDA). Prior to the current study, only 116 of the 832 woredas (districts) in Ethiopia had been mapped for LF. The aim of this study was to perform a nationwide mapping exercise to determine the number of people that should be targeted for MDA in 2016 when national coverage was anticipated.
Methodology/Principal Finding A two-stage cluster purposive sampling was used to conduct a community-based cross-sectional survey for an integrated mapping of LF and podoconiosis, in seven regional states and two city administrations. PLOS 09/10/15 What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs. Abstract Background Lymphatic filariasis (LF) is a neglected tropical disease for which more than a billion people in 73 countries are thought to be at-risk. At a global level, the efforts against LF are designed as an elimination program.
However, current efforts appear to aim for elimination in some but not all endemic areas. With the 2020 goal of elimination looming, we set out to develop plausible scale-up scenarios to reach global elimination and eradication. Methodology. PLOS 11/07/13 Population Genetics of the Filarial Worm Wuchereria bancrofti in a Post-treatment Region of Papua New Guinea: Insights into Diversity and Life History. Abstract Background Wuchereria bancrofti (Wb) is the primary causative agent of lymphatic filariasis (LF). Our studies of LF in Papua New Guinea (PNG) have shown that it is possible to reduce the prevalence of Wb in humans and mosquitoes through mass drug administration (MDA; diethylcarbamazine with/without ivermectin). While MDAs in the Dreikikir region through 1998 significantly reduced prevalence of Wb infection, parasites continue to be transmitted in the area.
Methods We sequenced the Wb mitochondrial Cytochrome Oxidase 1 (CO1) gene from 16 people infected with Wb. Principle Findings We discovered 109 unique haplotypes currently segregating in the Wb parasite population, with one common haplotype present in 15 out of 16 infections. PLOS 20/02/14 Mapping the Geographical Distribution of Lymphatic Filariasis in Zambia. Abstract Background Past case reports have indicated that lymphatic filariasis (LF) occurs in Zambia, but knowledge about its geographical distribution and prevalence pattern, and the underlying potential environmental drivers, has been limited. As a background for planning and implementation of control, a country-wide mapping survey was undertaken between 2003 and 2011.
Here the mapping activities are outlined, the findings across the numerous survey sites are presented, and the ecological requirements of the LF distribution are explored. Methodology/Principal findings Approximately 10,000 adult volunteers from 108 geo-referenced survey sites across Zambia were examined for circulating filarial antigens (CFA) with rapid format ICT cards, and a map indicating the distribution of CFA prevalences in Zambia was prepared. 78% of survey sites had CFA positive cases, with prevalences ranging between 1% and 54%.
INTERNATIONAL JOURNAL OF MEDICINE AND MEDICAL SCIENCES - MARS 2015 - Wuchereria bancrofti antigenaemia among school children: A case study of four communities in the Kassena-Nankana east district of the upper east region of Ghana. MEDECINE TROPICALE - Filariose lymphatique - Actualités 2015. CDC EID - Volume 20, Number 7—July 2014. Au sommaire notamment: Zoonotic Filariasis Caused by Novel Brugia sp. Nematode, United States, 2011. Highlight and copy the desired format. To the Editor: Zoonotic brugian filariasis is an incidental infection of humans with Brugia spp. nematodes that primarily parasitize nonhuman vertebrates, rarely humans (1–3). In contrast to classical lymphatic filariasis caused by B. malayi and B. timori, which are found in Asia, most zoonotic Brugia infections have been reported from the northeastern United States (2,3) or South America (3).
We report a case of symptomatic brugian infection in a New York City resident who had not traveled to the Eastern Hemisphere. In 2011, a 53-year-old White man first noted tenderness and swelling behind his penis and in his right groin after having fallen 3 months earlier. The tenderness was relieved by nonsteroidal antiinflammatory drugs, but the swelling continued; an oral antimicrobial drug, prescribed for presumed cellulitis, produced no improvement. Figure The prevalence of zoonotic infection with Brugia spp. nematodes is unknown. Acknowledgment References.
PLOS 29/05/14 Exploring the Potential of Flubendazole in Filariasis Control: Evaluation of the Systemic Exposure for Different Pharmaceutical Preparations. Infection, Genetics and Evolution 10 (2010) 159–177 Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE - 2011 - High prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemic.
PLOS 19/12/16 The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020. PLOS 01/12/16 Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs. PLOS 09/09/15 Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination. UNIVERSITE DE LILLE 2 20/05/11 Thèse en ligne : Le sel dans l'alimentation : un risque pour la santé ? INTECH - MARS 2012 - Lymphatic Filariasis Transmission and Control: A Mathematical Modelling Approach. Edited by Alfonso J. Rodriguez-Morales, ISBN 978-953-51-0274-8, 576 pages, Publisher: InTech, Chapters published March 16, 2012 under CC BY 3.0 licenseDOI: 10.5772/1335 Edited Volume Tropical Medicine has emerged and remained as an important discipline for the study of diseases endemic in the tropic, particularly those of infectious etiology.
MEDICAL JOURNAL ARMED FORCES INDIA - 2014 - Monitoring of malaria, Japanese encephalitis and filariasis vectors. PLOS - FEV 2010 - Detection of Wuchereria bancrofti L3 Larvae in Mosquitoes: A Reverse Transcriptase PCR Assay Evaluating Infect. Journal of Tropical Medicine Volume 2011 (2011) Current Evidence on the Use of Antifilarial Agents in the Management of Bancroft. OMS 17/09/10 17 September 2010, vol. 85, 38 (pp 365–372 )Programme mondial pour l’élimination de la filariose lymphatique.
JOURNAL OF VECTOR BORNE DISEASES - MARS 2011 - Au sommaire notamment:How endemic countries can accelerate lymphatic filariasis e.